Pyridinolcarbamate, bradykinin antagonist, in patients suffering from arteriosclerosis obliterans and thromboangiitis obliterans (Buerger's disease); a preliminary report on the treatment of human atherosclerosis.

Japanese heart journal ·Vol. 6 ·No. 5 ·1965-09-00 ·Pages 407-15

Shimamoto T, Atsumi T

Abstract

暂无摘要

MeSH Terms

Adult Antimetabolites/therapeutic use Arteriosclerosis Obliterans/drug therapy Blood Coagulation/drug effects Bradykinin Carbamates/therapeutic use Cholesterol Humans Male Middle Aged Thromboangiitis Obliterans/drug therapy Vasodilator Agents/therapeutic use

Chemicals

Antimetabolites Carbamates Vasodilator Agents Cholesterol Bradykinin

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

Shimamoto T

Atsumi T

Article Info

Journal

Japanese heart journal

Abbr.

Jpn Heart J

ISSN

0021-4868

DOI

10.1536/ihj.6.407

Published

1965-09-00

Pages

407-15

Language

English

Region

Japan

NLM ID

0401175

Subset

External Links

PubMed source DOI: 10.1536/ihj.6.407

Analysis Services

Pyridinolcarbamate, bradykinin antagonist, in patients suffering from arteriosclerosis obliterans and thromboangiitis obliterans (Buerger's disease); a preliminary report on the treatment of human atherosclerosis.

Contact

WeChat Official Account